Alcohol
Volume 25, Issue 2 , Pages 69-75 , October 2001

Cation modulation of GABAA receptors in brain sections of AT and ANT rats

  • Mikko Uusi-Oukari

      Affiliations

    • Department of Pharmacology and Clinical Pharmacology, University of Turku, 20520 Turku, Finland
    • Corresponding Author InformationCorresponding author. Department of Pharmacology and Clinical Pharmacology, University of Turku, Kiinamyllynkatu 10, FIN-20520 Turku, Finland. Tel.: +358-2-333-7542; fax: +358-2-333-7216
    • ,
  • Riikka Mäkelä

      Affiliations

    • Department of Mental Health and Alcohol Research, National Public Health Institute, 00300 Helsinki, Finland
    • ,
  • Sanna Soini

      Affiliations

    • Department of Pharmacology and Clinical Pharmacology, University of Turku, 20520 Turku, Finland
    • ,
  • Esa R. Korpi

      Affiliations

    • Department of Pharmacology and Clinical Pharmacology, University of Turku, 20520 Turku, Finland

Received 21 February 2001 ,Revised 15 May 2001 ,Accepted 21 May 2001.

References 

  1. Calton JL, Wilson WA, Moore SD. Magnesium-dependent inhibition of N-methyl-d-aspartate receptor–mediated synaptic transmission by ethanol. J Pharmacol Exp Ther. 1998;287:1015–1019
  2. Chu B, Anantharam V, Treistman SN. Ethanol inhibition of recombinant heteromeric NMDA channels in the presence and absence of modulators. J Neurochem. 1995;65:140–148
  3. Crews FT, Morrow AL, Criswell H, Breese G. Effects of ethanol on ion channels. Int Rev Neurobiol. 1996;39:283–367
  4. Durlach J, Bac P, Durlach V, Durlach A, Bara M, Guiet-Bara A. Are age-related neurodegenerative diseases linked with various types of magnesium depletion?. Magnes Res. 1997;10:339–353
  5. Elin RJ. Magnesium: the fifth but forgotten electrolyte. Am J Clin Pathol. 1994;102:616–622
  6. Eriksson K, Rusi M. Finnish selection studies on alcohol-related behaviors: general outline. In:  McClearn GE,  Deitrich RA,  Erwin G editor. Development of Animal Models as Pharmacogenetic Tools. Washington, DC: U.S. Government Printing Office; 1981;p. 87–117NIAAA Research Monograph No. 6
  7. Faingold CL, N'Gouemo P, Riaz A. Ethanol and neurotransmitter interactions: from molecular to integrative effects. Prog Neurobiol. 1998;55:509–535
  8. Glue P, Nutt D. Overexcitement and disinhibition: dynamic neurotransmitter interactions in alcohol withdrawal. Br J Psychiatry. 1990;157:491–499
  9. Hellevuo K, Kiianmaa K, Korpi ER. Effect of GABAergic drugs on motor impairment from ethanol, barbital and lorazepam in rat lines selected for differential sensitivity to ethanol. Pharmacol Biochem Behav. 1989;34:399–404
  10. Im WB, Blakeman DP. Correlation between γ-aminobutyric acidA receptor ligand–induced changes in t-butylbicyclophosphoro [35S]thionate binding and 36Cl- uptake in rat cerebrocortical membranes. Mol Pharmacol. 1991;39:394–398
  11. Im WB, Pregenzer JF. Interaction of La3+ with GABAA receptors in rat cerebrocortical membranes as detected with [35S]t-butylbicyclophosphorothionate binding. Eur J Pharmacol. 1993;245:111–117
  12. Korpi ER, Kleingoor C, Kettenmann H, Seeburg PH. Benzodiazepine-induced motor impairment linked to point mutation in cerebellar GABAA receptor. Nature. 1993;361:356–359
  13. Korpi ER, Kuner T, Seeburg PH, Lüddens H. Selective antagonist for the cerebellar granule cell–specific gamma-aminobutyric acid type A receptor. Mol Pharmacol. 1995;47:283–289
  14. Korpi ER, Mäkelä R, Uusi-Oukari M. Ethanol: novel actions on nerve cell physiology explain impaired functions. News Physiol Sci. 1998;13:164–170
  15. Korpi ER, Seeburg PH, Lüddens H. Modulation of GABAA receptor tert-[35S]butylbicyclophosphorothionate binding by antagonists: relationship to patterns of subunit expression. J Neurochem. 1996;66:2179–2187
  16. Korpi ER, Uusi-Oukari M, Castren E, Suzdak PD, Seppälä T, Sarviharju M, et al. Cerebellar GABAA receptors in two rat lines selected for high and low sensitivity to moderate alcohol doses: pharmacological and genetic studies. Alcohol. 1992;9:225–231
  17. Kume A, Sakurai SY, Albin RL. Zinc inhibition of t-[35H]butylbicycloorthobenzoate binding to the GABAA receptor complex. J Neurochem. 1994;62:602–607
  18. Makela R, Lehtonen M, Wisden W, Lüddens H, Korpi ER. Blunted furosemide action on cerebellar GABAA receptors in ANT rats selectively bred for high alcohol sensitivity. Neuropharmacology. 1996;35:1493–1502
  19. Makela R, Uusi-Oukari M, Oja SS, Alho H, Anghelescu I, Klawe C, et al. Furosemide action on cerebellar GABAA receptors in alcohol-sensitive ANT rats. Alcohol. 1999;19:197–205
  20. Maksay G, Korpi ER, Uusi-Oukari M. Bimodal action of furosemide on convulsant [3H]EBOB binding to cerebellar and cortical GABAA receptors. Neurochem Int. 1998;33:353–358
  21. Malminen O, Korpi ER. GABA/benzodiazepine receptor/chloride ionophore complex in brains of rat lines selectively bred for differences in ethanol-induced motor impairment. Alcohol. 1988;5:239–249
  22. Martin D, Morrisett RA, Bian XP, Wilson WA, Swartzwelder HS. Ethanol inhibition of NMDA mediated depolarizations is increased in the presence of Mg2+. Brain Res. 1991;546:227–234
  23. Mayer ML, Westbrook GL, Guthrie PB. Voltage-dependent block by Mg2+ of NMDA responses in spinal cord neurones. Nature. 1984;309:261–263
  24. Moykkynen T, Uusi-Oukari M, Heikkila J, Lovinger DM, Lüddens H, Korpi ER. Magnesium potentiation of the function of native and recombinant GABAA receptors. Neuroreport. 2001;12:2175–2179
  25. Nowak L, Bregestovski P, Ascher P, Herbet A, Prochiantz A. Magnesium gates glutamate-activated channels in mouse central neurones. Nature. 1984;307:462–465
  26. Peoples RW, White G, Lovinger DM, Weight FF. Ethanol inhibition of N-methyl-d-aspartate–activated current in mouse hippocampal neurones: whole-cell patch-clamp analysis. Br J Pharmacol. 1997;122:1035–1042
  27. Saxena NC, Macdonald RL. Properties of putative cerebellar gamma-aminobutyric acid A receptor isoforms. Mol Pharmacol. 1996;49:567–579
  28. Saxena NC, Neelands TR, Macdonald RL. Contrasting actions of lanthanum on different recombinant gamma-aminobutyric acid receptor isoforms expressed in L929 fibroblasts. Mol Pharmacol. 1997;51:328–335
  29. Schmid G, Bonanno G, Raiteri L, Sarviharju M, Korpi ER, Raiteri M. Enhanced benzodiazepine and ethanol actions on cerebellar GABAA receptors mediating glutamate release in an alcohol-sensitive rat line. Neuropharmacology. 1999;38:1273–1279
  30. Schmid G, Chittolini R, Raiteri L, Bonanno G. Differential effects of zinc on native GABAA receptor function in rat hippocampus and cerebellum. Neurochem Int. 1999;34:399–405
  31. Schwartz RD, Wagner JP, Yu X, Martin D. Bidirectional modulation of GABA-gated chloride channels by divalent cations: inhibition by Ca2+ and enhancement by Mg2+. J Neurochem. 1994;62:916–922
  32. Shane SR, Flink EB. Magnesium deficiency in alcohol addiction and withdrawal. Magnes Trace Elem. 1991;10:263–268
  33. Squires RF, Casida JE, Richardson M, Saederup E. [35S]t-Butylbicyclophosphorothionate binds with high affinity to brain-specific sites coupled to γ-aminobutyric acid-A and ion recognition sites. Mol Pharmacol. 1983;23:326–336
  34. Uusi-Oukari M, Korpi ER. Cerebellar GABAA receptor binding and function in vitro in two rat lines developed for high and low alcohol sensitivity. Neurochem Res. 1989;14:733–739
  35. Uusi-Oukari M, Korpi ER. Diazepam sensitivity of the binding of an imidazobenzodiazepine, [3H]Ro 15-4513, in cerebellar membranes from two rat lines developed for high and low alcohol sensitivity. J Neurochem. 1990;54:1980–1987
  36. Uusi-Oukari M, Korpi ER. Functional properties of GABAA receptors in two rat lines selected for high and low alcohol sensitivity. Alcohol. 1992;9:261–269
  37. Welch KM. Pathogenesis of migraine. Semin Neurol. 1997;17:335–341

PII: S0741-8329(01)00169-0

Alcohol
Volume 25, Issue 2 , Pages 69-75 , October 2001

Article Tools

* Image Usage & Resolution